A Case Report of EGFR-mutated Metastatic Lung Adenocarcinoma with Long-term Survival on Systemic Treatment
Journal of Medical and Radiation Oncology · 2021
DOI: 10.53011/jmro.2021.01.05 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical and Radiation Oncology, 2021. Verfasst von Daniel Dulf und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
"Metastatic non-small cell lung cancer has historically been associated with a poor prognosis. The introduction of targeted agents against certain molecules involved in cellular pathways has shown improved responses, but long-term survivors are still rare. We present the case of a patient with lung adenocarcinoma harboring sensitizing EGFR mutations who showed an impressive survival of more than 9 years following a combination of systemic therapies consisting of cytotoxic drugs and EGFR TKIs that were very well tolerated."
Zitieren
APA
Dulf, D., Kubelak, P., Iancu, D., & Ciuleanu, T. (2021). A Case Report of EGFR-mutated Metastatic Lung Adenocarcinoma with Long-term Survival on Systemic Treatment. Journal of Medical and Radiation Oncology. https://doi.org/10.53011/jmro.2021.01.05
Vancouver
Dulf D, Kubelak P, Iancu D, Ciuleanu T. A Case Report of EGFR-mutated Metastatic Lung Adenocarcinoma with Long-term Survival on Systemic Treatment. Journal of Medical and Radiation Oncology. 2021. doi:10.53011/jmro.2021.01.05
BibTeX
@article{Dulf2021,
author = {Dulf, Daniel and Kubelak, Paul and Iancu, Dana and Ciuleanu, Tudor-Eliade},
title = {A Case Report of EGFR-mutated Metastatic Lung Adenocarcinoma with Long-term Survival on Systemic Treatment},
journal = {Journal of Medical and Radiation Oncology},
year = {2021},
doi = {10.53011/jmro.2021.01.05}
}
EUVIMED